SkinHealth Systems Inc. (NASDAQ: SKIN) is a Healthcare company (Medical - Specialties) with a market capitalization of $106M. The Maz Rating grades it against the other companies in its sector.
SkinHealth Systems Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $16.31, SkinHealth Systems Inc. trades at 0.4x sales and 1.9x book value, with an EV/EBITDA of 7.7. Over the last twelve months it generated about $289M of revenue and a net loss of $19M. It runs a gross margin of 67.2%, an operating margin of 2.4% and a net margin of -6.3%. It shows return on equity of -32.1%, return on invested capital of 2.1% and a free cash flow yield of 17.2%. On the balance sheet: a debt-to-equity ratio of 4.74 and a current ratio of 2.89. Over the past 52 weeks the share price ranged from $9.68 to $33.00, with a beta of 1.05.
SkinHealth Systems Inc. does not currently pay a dividend.
14 Wall Street analyst ratings cover the stock: 4 Buy, 7 Hold and 3 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.